Dow Jones

38 852,86

-0,55%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Osiris Therape (MM) (OSIR)
Osiris Therape (MM) (OSIR) Actualités

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OSIR

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
29/04/2019	22h13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h48	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h05	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	12h08	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	12h08	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
20/03/2019	12h43	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OSIR	Osiris Therape (MM)
20/03/2019	12h33	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:OSIR	Osiris Therape (MM)
15/03/2019	23h13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
15/03/2019	14h03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	22h10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	22h03	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	18h14	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	14h33	PR Newswire (US)	Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	14h00	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc	NASDAQ:OSIR	Osiris Therape (MM)
28/02/2019	15h00	GlobeNewswire Inc.	Predictive Technology Group Names Jay M. Moyes to Its Board of Directors	NASDAQ:OSIR	Osiris Therape (MM)
29/11/2018	22h24	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OSIR	Osiris Therape (MM)
26/11/2018	22h30	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer	NASDAQ:OSIR	Osiris Therape (MM)
07/11/2018	22h25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OSIR	Osiris Therape (MM)
07/11/2018	22h15	GlobeNewswire Inc.	Osiris Therapeutics, Inc Reports Third Quarter 2018 Results	NASDAQ:OSIR	Osiris Therape (MM)
30/10/2018	21h30	GlobeNewswire Inc.	Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fa...	NASDAQ:OSIR	Osiris Therape (MM)
02/10/2018	22h30	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living ...	NASDAQ:OSIR	Osiris Therape (MM)
17/09/2018	23h00	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018	NASDAQ:OSIR	Osiris Therape (MM)
27/08/2018	22h30	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membra...	NASDAQ:OSIR	Osiris Therape (MM)
31/07/2018	16h33	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	NASDAQ:OSIR	Osiris Therape (MM)
27/07/2018	22h05	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NASDAQ:OSIR	Osiris Therape (MM)
25/07/2018	22h33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OSIR	Osiris Therape (MM)
11/05/2018	20h31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:OSIR	Osiris Therape (MM)